Global Oral Live Cholera Vaccines Market Size By Vaccine Type, By Product, By Application, By Geographic Scope And Forecast

Oral Live Cholera Vaccines Market Size And Forecast

Oral Live Cholera Vaccines Market is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.

The increasing incidences of cholera, rising initiatives by public and private entities, and growing awareness about cholera around the world are all contributing to the Global Oral Live Cholera Vaccines Market. In 2017, a stockpile was used to fund 10 million doses of oral cholera vaccine in affected countries. Travelers and people who live in cholera-affected areas are the main recipients of these vaccines. Furthermore, the cholera vaccine should be taken at least 2 weeks before arrival at the destination and at least 1 week between doses, according to WHO. As a result, the aforementioned factors contribute to the growth of the global Oral Live Cholera Vaccines Market. The Global Oral Live Cholera Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Oral Live Cholera Vaccines Market Definition

In the United States, the FDA recently approved Vaxchora® (lyophilized CVD 103-HgR), a single-dose live oral cholera vaccine. The vaccine has been approved by the Advisory Committee on Immunization Practices (ACIP) for adults aged 18 to 64 who are traveling to an active cholera transmission area. Cholera Vaccine is a live, attenuated (weakened) vaccine that lasts at least 7 days in the stool. After receiving the cholera vaccine, you may experience fatigue, headache, abdominal pain, nausea, vomiting, a loss of appetite, and diarrhea.

Cholera is an infectious disease that causes severe watery diarrhea, which can lead to dehydration and even death if untreated. It is caused by eating food or drinking water contaminated with a bacterium called Vibrio cholera. Cholera, an acute infection of the small intestine caused by the bacterium Vibrio cholera and characterized by extreme diarrhea with rapid and severe depletion of body fluids and salts.

This vaccine protects against cholera, which is caused by some specific bacteria (V. cholera). People can become infected by eating contaminated food or drinking contaminated water. Adults who are traveling to areas where this infection is common should get this vaccine. The cholera vaccine is given to people who plan to travel to areas where cholera is common to help prevent the disease. This vaccine protects you from cholera by exposing you to a small dose of live cholera bacteria, which causes your body to develop immunity to the disease.

Global Oral Live Cholera Vaccines Market Overview

A vaccine is a biological preparation that aids in immune system strengthening and provides acquired immunity to a specific pathogen. Many international organizations, including the World Health Organization, have determined that vaccinations are one of the most effective ways to treat infectious diseases (WHO). Cholera is one of the infectious diseases caused by the Vibrio cholera bacterium. It’s linked to severe diarrhea, and it needs to be treated right away because if the disease isn’t treated, it’ll kill you. Cholera is expected to be a global threat to public health, particularly in underdeveloped areas. As a result, the cholera vaccine is critical for cholera control. There are two types of cholera vaccines on the marketinactivated and live oral cholera vaccines, with inactivated cholera vaccines being used successfully around the world.

Vaxchora comes in two packetsone with the active component and another with the buffer component. Following the buffer, the active component is added to 100 mL of cold water. Several antibiotics, including doxycycline, ciprofloxacin, and azithromycin, are effective in the treatment of cholera if the cholera strain is susceptible. Cholera is an infectious disease that causes extreme watery diarrhea and may result in dehydration and even death if left untreated. It is contracted by ingesting food or drinking water contaminated with the Vibrio cholera bacterium.

Cholera is an acute infection of the small intestine caused by the bacterium Vibrio cholera, which is characterized by severe diarrhea and a rapid and severe loss of body fluids and salts. The high prevalence of chronic diseases, lack of proper sanitation and consumption of contaminated food, and growing awareness about cholera preventive care are all driving demand for the Global Oral Live Cholera Vaccines Market. Furthermore, the demand is being influenced by the emergence of innovative methods for new Cholera Vaccines, as well as a greater emphasis on immunization initiatives by governments.

However, the need for longer timelines for Cholera Vaccine production, the risk of side effects, the high costs associated with vaccine development, and the time it takes for regulation of these factors are likely to hinder the growth of the Oral Live Cholera Vaccines Market. Cholera Vaccine manufacturers, on the other hand, are projected to benefit handsomely from high growth prospects in untapped markets. However, a lack of adequate cholera care, combined with a large number of unreported cases, is expected to slow the market’s growth.

Global Oral Live Cholera Vaccines MarketSegmentation Analysis

The Global Oral Live Cholera Vaccines Market is Segmented on the basis of Vaccine Type, Product, Application, and Geography.

Oral Live Cholera Vaccines Market, By Vaccine Type

• Whole cell V. cholera O1 with Recombinant B-subunit• Killed Oral O1 and O139

Based on Vaccine Type, the market is segmented into Whole cell V. cholera O1 with Recombinant B-subunit and Killed Oral O1 and O139.

Oral Live Cholera Vaccines Market, By Product

• Vaxchora• Dukoral• Shanchol• Other Products

Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol, and Other Products.

Oral Live Cholera Vaccines Market, By Application

• Hospital• Research and Academic Laboratories• Pharmaceutical and Biotechnology Companies• Others

Based on Application, the market is segmented into Hospital, Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies, and Others.

Oral Live Cholera Vaccines Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Oral Live Cholera Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world.

Key Players In Oral Live Cholera Vaccines Market

The “Global Oral Live Cholera Vaccines Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Emergent Bio Solutions Inc., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma, Inc., Sanofi, EU Biologics Co., Ltd., Johnson & Johnson, Celldex Therapeutics, Inc., Merck & Co., Inc., GlaxoSmithKline plc., and Takeda Pharmaceutical Co. Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.